The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE INC | COM | 00032Q104 | 1,155,000 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | |||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 360,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | |||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 3,956,000 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | |||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 4,658,000 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 12,933,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 15,513,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 15,877,000 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | |||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 6,701,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | |||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 2,219,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 18,126,000 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | |||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 2,583,000 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 876,000 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 9,248,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | |||
CTI BIOPHARMA CORP | COM | 12648L601 | 11,119,000 | 1,850,000 | SH | SOLE | 1,850,000 | 0 | 0 | |||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 850,000 | 82,853 | SH | SOLE | 82,853 | 0 | 0 | |||
INVESCO QQQ TR | UNIT SER 1 | 46090E103 | 13,314,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 8,307,000 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | |||
IVERIC BIO INC | COM | 46583P102 | 9,635,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | |||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 7,860,000 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 2,393,000 | 339,907 | SH | SOLE | 339,907 | 0 | 0 | |||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 5,805,000 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 9,062,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 1,089,000 | 9,896 | SH | SOLE | 9,896 | 0 | 0 | |||
PROVENTION BIO INC | COM | 74374N102 | 4,228,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
RAPT THERAPEUTICS INC | COM | 75382E109 | 2,475,000 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | |||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 18,995,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
REVANCE THERAPEUTICS INC | COM | 761330109 | 5,538,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 7,127,000 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | |||
SEAGEN INC | COM | 81181C104 | 10,923,000 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,818,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 1,173,000 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 7,672,000 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | |||
VIKING THERAPEUTICS INC | COM | 92686J106 | 2,820,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 4,820,000 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | |||
X4 PHARMACEUTICALS INC | COM | 98420X103 | 993,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 |